Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone with or without losartan for microalbuminuria in type 2 diabetes
IRCT138806211241N2Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of spironolactone and losartan in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Mazandaran University of Medical Sciences. Started Oct 2009; status: completed.
02
Drugs
spironolactonelosartan
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT138806211241N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138806211241N2.